291 top medical experts on Fetal Erythroblastosis across 47 countries and 28 U.S. states, including 143 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Fetal Erythroblastosis: A condition characterized by the abnormal presence of erythroblasts in the circulation of the fetus or newborns. It is a disorder due to blood group incompatibility, such as the maternal alloimmunization by fetal antigen RH factors leading to hemolysis of erythrocytes, hemolytic anemia (anemia, hemolytic), general edema (hydrops fetalis), and severe jaundice IN newborn.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Diseases Newborn Infant (2,780), Fetal Diseases (2,802), Hematologic Diseases (2,132), Immune System Diseases (1,465) and Narrower Categories: Hydrops Fetalis (2,366), Kernicterus (490).
  4. Clinical Trials ClinicalTrials.gov : at least 6 including 2 Completed, 1 Recruiting
  5. Synonyms: Hemolytic Disease of Newborn


  

        

                    


    Computing Expert Listing ...

);